Back to results
TerminatedPhase 3

The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer

NCT00097344

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Mobile, Alabama, United States

+103 additional locations

View on ClinicalTrials.gov
The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer — TrialFind